BIT's 15th Annual Congress of International Drug Discovery Science and Technology - Japan 2017 (IDDST-Japan 2017)
★ Scientific Program

BIT's 15th Annual Congress of

International Drug Discovery Science and Technology - Japan 2017

Theme: Dedicated to Accelerating Drug Innovation

Time: July 25-27, 2017

Venue: Osaka, Japan

 

Keynote Forum Scientific Program
Section 1 Section 2 Section 3 Section 4 Section 5 Section 6 Young Scientist Forum

 

Section 1: Pharmacology and Toxicology
Session 101: ADME-Tox and Predictive Pharmacology
Day 1: Afternoon, Tuesday, July 25, 2017
13:00-15:10
Place: Saki, 2F, Banquet Tower, HRO
Chair: Dr. Zoltan Timar, Head, Bioanalytical Laboratory, SOLVO Biotechnology, Hungary
Time FaceOn Speeches and Speakers Org. Logo
13:00-13:05 Chair's Introduction
13:05-13:30 Title: Protoapigenon Derivatives in Drug Discovery: Pharmacokinetics and Bioanalysis
Dr. Zoltan Timar,
Head, Bioanalytical Laboratory, SOLVO Biotechnology, Hungary
13:30-13:55 Title: Patient-controlled Analgesia with Target Controlled Infusion of Hydromorphone: From Computer Simulation to Clinical Validation of a New Opioid Therapy Concept for Postoperative Pain Treatment
Dr. Christian Jeleazcov,
Associate Professor, Department of Anesthesiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Germany
13:55-14:20 Title: Zebrafish Embryos as a Model for Studying the Toxicity of Mycotoxin
Dr. Biing-Hui Liu,
Professor, National Taiwan University, Taiwan
14:20-14:45 Title: Protective Effect of ECQon the GI Inflammation
Dr. Uy Dong Sohn,
Professor, Chung-Ang University, South Korea
14:45-15:10 Title: Direct Visualization of DNA Damage and Epigenetic Transformations for Quantitative Genotoxicity Assesment
Dr. Yuval Ebenstein,
Senior Lecturer, Tel Aviv University, Israel
15:10-15:25 Coffee Break

  

Session 102: Neuropsychopharmacology
Day 2: Morning, Wednesday, July 26, 2017
08:30-11:45
Place: Saki, 2F, Banquet Tower, HRO
Chair: Dr. Dinah Weissmann, Executive VP R&D, Alcediag, France
Time FaceOn Speeches and Speakers Org. Logo
08:30-08:35 Chair's Introduction
08:35-09:00 Title: Neuroreceptors and Neurotransmitters:  Latest Frontiers for Psychotropic Drug Development
Dr. Rakesh Ranjan,
Executive Medical Director, Charak Clinical Research Center, USA
09:00-09:25 Title: Predicting Drug-induced Neurotoxicity and Psychiatric Side Effects Using Specific RNA Editing Biomarkers
Dr. Dinah Weissmann,
Executive VP R&D, Alcediag, France
09:25-09:50 Title: Selective Prolyl Oligopeptidase Inhibition as a New Pharmacological Treatment of the Cognitive Impairment Associated with Schizophrenia
Dr. Teresa Tarrago,
Chief Executive Officer, Iproteos S.L., Spain
09:50-10:15 Title: Effects of Adipokinetic Hormone/Red Pigment-concentrating Hormone (AKH/RPCH) Family of Peptides in Mice
Dr. Oguz Mutlu,
Associate Professor, Kocaeli University, Turkey
10:15-10:30 Coffee Break
10:30-10:55 Title: Extension of Therapeutic Time Window of Tissue Plasminogen Activator with SP-8203 Combination Therapy in Rat Embolic Stroke Models
Dr. Won-Ki Kim,
Chairman, Department of Neuroscience, Korea University College of Medicine, South Korea
10:55-11:20 Title: Molecular Design of Ginkgolide PET Probes with Brain Permeability
Dr. Masaaki Suzuki, Specially Approved Project Researcher, National Center for Geriatrics and Gerontology, Japan
Your Logo Here
11:20-11:45 Title: Ketamine Use in Relation to Psychosocial Problems
Dr. Hao-Jan Yang,
Associate Professor, Chung Shan Medical University, Taiwan

 

Session 103: Clinical Pharmacology and Toxicology
Day 2: Afternoon, Wednesday, July 26, 2017
13:00-15:10
Place: Saki, 2F, Banquet Tower, HRO
Chair: Dr. Ling Gao, Principal Research Scientist, Global PKPD & Pharmacometrics, Eli Lilly and Company, USA
Time FaceOn Speeches and Speakers Org. Logo
13:00-13:05 Chair's Introduction
13:05-13:30 Title: Clinical Pharmacology Properties of CYRAMZA in Cancer Patients
Dr. Ling Gao,
Principal Research Scientist, Global PKPD & Pharmacometrics, Eli Lilly and Company, USA
13:30-13:55    Title: Pre-clinical and Clinical Studies in COPD and Cardiovascular Areas and the Role of Biomarkers
Dr. Nikolai V. Ivanov,
Manager, Philip Morris International R & D, Philip Morris Products S.A., Switzerland
 
13:55-14:20 Title: Comparative Single-Dose Pharmacokinetics of Bupropion and Metabolites in Adolescents and Adults; Potential Impact of Treating Children off Label
Dr. Christopher Crean,
Executive Pharmaceutical Consultant, Chatham Biopharma Consulting, LLC., USA
14:20-14:45 Title: The Effect of Inclusion and Exclusion of Grey Literature on the Results of Meta-analyses of Randomized Trial
Dr. Giovanni Dondi Dall’Orologio,
Associate Professor, University of Bologna, Italy
14:45-15:10   Title: A Compound Inhibits Jointly Phosphodiesterase 1 and 5
Dr. Geng-Long Hsu, 
Former Clinical Professor, Hsu’s Andrology & National Taiwan University, Taiwan
 
15:10-15:25 Coffee Break

 

Session 104: Pharmacovigilance, Drug Safety and Risk Management
Day 3: Morning,  Thursday, July 27, 2017
08:30-11:45
Place: Saki, 2F, Banquet Tower, HRO
Chair: Dr. Joseph P. Thomas, Chair of the Life Sciences Group and Co-chair of the Litigation Department, Ulmer & Berne LLP, USA
Time FaceOn Speeches and Speakers Org. Logo
08:30-08:35 Chair's Introduction
08:35-09:00 Title: Unique Challenges in Labeling Biosimilar Products in the U.S.
Dr. Joseph P. Thomas,
Chair of the Life Sciences Group and Co-chair of the Litigation Department, Ulmer & Berne LLP, USA
09:00-09:25 Title: The Scientific and Regulatory Aspects of Abuse Potential Assessment
Dr. Thomas Hudzik, Senior Consultant, ALA Biopharma Consulting, USA
09:25-09:50 Title: Breastfeeding and Vigilance, Contaminants during Lactation. What about Methyl Mercury in Human Breastmilk in France?
Dr. Raphael Serreau, Professor of Clinical Research, Leonard Vinci Institute, France
09:50-10:15 Title: The Effect on Potential Adverse Drug Events of a Pharmacist-acquired Medication History in an Emergency Department: A Multicentre, Double-Blind, Randomised, Controlled, Parallel-group Study
Dr. Jesus Becerra-Camargo,
Associate Professor, National University of Colombia, Colombia
10:15-10:30 Coffee Break
10:30-10:55 Title: Pharmacokinetic-pharmacodynamic Principles and Drug Overdose in Anaesthesia
Dr. Jamal Tashkandi,
Assistant Professor, Umm Alqura University, Saudi Arabia
10:55-11:20 Title: Understanding the Pharmacology and Toxicology Properties of Transdermal Buprenorphine and Fentanyl to Ensure the Safety and Efficacy of Drugs Use
Dr. Christina Yuen Ki Leung,
Senior Pharmacist, The University of Hong Kong-Shenzhen Hospital (HKU-SZH), China
11:20-11:45 Title: Towards a Rehabilitative South African Criminal Law Response to Drug Abuse: A Recommendation for Medical Oriented Drug Weaning
Ms. Mampolokeng Mathuso Mary-Elizabeth Monyakane,
Senior Lecturer, University of South Africa (UNISA), South Africa

 

Session 105: Pharmacogenomics in Precision Medicine
Day 3: Afternoon,  Thursday, July 27, 2017
13:00-15:10
Place: Saki, 2F, Banquet Tower, HRO
Chair: Dr. Jean Gabert, Professor, Aix Marseille University, France
Time FaceOn Speeches and Speakers Org. Logo
13:00-13:05 Chair's Introduction
13:05-13:30   Title: CalR and MPL Gene Mutations in Primary  Myeloproliferative Syndroms for Personalized Medicine
Dr. Jean Gabert, Professor, Aix Marseille University, France
13:30-13:55 Title: Fumonisin B1 Induces Global DNA Hypomethylation in HepG2 Cells
Dr. Anil A Chuturgoon, Professor, University of KwaZulu-Natal, South Africa
13:55-14:20

Title: Association between UGT1A1*28 Polymorphisms and Clinical Outcomes and Toxicities of Irinotecan-based Chemotherapies in Colorectal Cancer
Dr. Wei Xu, Principal Biostatistician, Princess Margaret Cancer Centre, Canada

14:20-14:45 Title: Genetic Polymorphisms Associated with Ultra-rapid Metabolism Demonstrate Protective Effect on Metabolic Complications of Clozapine Treatment
Dr. Irina Piatkov, Senior Hospital Scientist, Blacktown Molecular Research Laboratory, Clinical School and Research Centre, Western Sydney Local Health District, Australia
14:45-15:10 Title: Pharmacogenomics in Clinical Practice in Thailand: The Lesson Learned from Case Studies
Dr. Chonlaphat Sukasem, Associate Professor, Mahidol University, Thailand
15:10-15:25 Coffee Break

Hosting Organization
whtslogo.JPG
World High Technology Society
Operating Organization
BIT Group Global Ltd.
Supporting Organizations

Keio University School of Medicine, Japan

Nagoya University Graduate School of Pharmaceutical Sciences, Japan

Shenzhen International Institute for Biomedical Research, China

Official Travel Agency
Media Partners

Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2016-2017 BIT Group Global Ltd.